News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
56,317 Results
Type
Article (4904)
Company Profile (17)
Press Release (51394)
Multimedia
Podcasts (1)
Webinars (4)
Section
Business (17063)
Career Advice (263)
Deals (2651)
Drug Delivery (11)
Drug Development (2907)
Employer Resources (23)
FDA (1114)
Job Trends (1698)
News (24097)
Policy (2122)
Tag
Academia (561)
Allergies (3)
Alliances (5778)
ALS (6)
Alzheimer's disease (135)
Antibody-drug conjugate (ADC) (24)
Approvals (1129)
Artificial intelligence (123)
Autoimmune disease (13)
Automation (22)
Bankruptcy (24)
Best Places to Work (1174)
BIOSECURE Act (1)
Biosimilars (26)
Biotechnology (8)
Bladder cancer (3)
Brain cancer (4)
Breast cancer (34)
Cancer (324)
Cardiovascular disease (29)
Career advice (234)
Career pathing (12)
CAR-T (15)
CDC (2)
Cell therapy (50)
Cervical cancer (11)
Clinical research (1999)
Collaboration (231)
Compensation (8)
Complete response letters (1)
COVID-19 (436)
CRISPR (13)
C-suite (63)
Cystic fibrosis (9)
Data (316)
Denatured (1)
Depression (4)
Diabetes (16)
Diagnostics (1829)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (47)
Drug pricing (6)
Drug shortages (2)
Duchenne muscular dystrophy (3)
Earnings (4626)
Editorial (3)
Employer branding (2)
Employer resources (21)
Events (5951)
Executive appointments (87)
FDA (1283)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (190)
Gene editing (22)
Generative AI (10)
Gene therapy (35)
GLP-1 (61)
Government (475)
Grass and pollen (1)
Guidances (24)
Healthcare (1528)
HIV (6)
Huntington's disease (2)
IgA nephropathy (2)
Immunology and inflammation (16)
Immuno-oncology (4)
Indications (2)
Infectious disease (472)
Inflammatory bowel disease (15)
Influenza (33)
Intellectual property (11)
Interviews (34)
IPO (902)
IRA (4)
Job creations (516)
Job search strategy (198)
JPM (11)
Labor market (20)
Layoffs (44)
Leadership (15)
Legal (354)
Liver cancer (2)
Longevity (3)
Lung cancer (32)
Lymphoma (25)
Machine learning (15)
Management (5)
Manufacturing (108)
MASH (2)
Medical device (1016)
Medtech (1021)
Mergers & acquisitions (1842)
Metabolic disorders (45)
Multiple sclerosis (6)
Neurodegenerative disease (19)
Neuropsychiatric disorders (3)
Neuroscience (218)
Neurotech (1)
NextGen: Class of 2026 (715)
Non-profit (549)
Now hiring (19)
Obesity (26)
Opinion (55)
Ovarian cancer (10)
Pain (8)
Pancreatic cancer (12)
Parkinson's disease (25)
Partnered (9)
Patents (19)
Patient recruitment (16)
Peanut (3)
People (4860)
Pharmaceutical (2)
Phase 1 (726)
Phase 2 (885)
Phase 3 (692)
Pipeline (439)
Policy (13)
Postmarket research (91)
Preclinical (510)
Press Release (18)
Prostate cancer (21)
Psychedelics (5)
Radiopharmaceuticals (13)
Rare diseases (38)
Real estate (1444)
Recruiting (13)
Regulatory (1555)
Reports (11)
Research institute (531)
Resumes & cover letters (31)
Rett syndrome (3)
RNA editing (1)
RSV (6)
Schizophrenia (7)
Series A (35)
Series B (20)
Service/supplier (2)
Sickle cell disease (2)
Special edition (3)
Spinal muscular atrophy (5)
Sponsored (8)
Startups (502)
Stomach cancer (1)
Supply chain (11)
Tariffs (4)
Vaccines (44)
Venture capital (20)
Weight loss (15)
Women's health (10)
Worklife (5)
Date
Last 7 days (43)
Last 30 days (168)
Last 365 days (2178)
2026 (210)
2025 (2202)
2024 (2726)
2023 (3286)
2022 (4747)
2021 (4998)
2020 (5651)
2019 (4215)
2018 (3015)
2017 (2942)
2016 (3146)
2015 (3166)
2014 (2184)
2013 (1946)
2012 (2079)
2011 (2192)
2010 (1620)
Location
Africa (108)
Alabama (10)
Alaska (1)
Arizona (29)
Arkansas (1)
Asia (3165)
Australia (419)
California (787)
Canada (234)
China (78)
Colorado (38)
Connecticut (93)
Delaware (15)
Europe (6294)
Florida (61)
Georgia (26)
Idaho (6)
Illinois (56)
India (13)
Indiana (62)
Iowa (7)
Japan (24)
Kansas (6)
Kentucky (3)
Louisiana (3)
Maine (6)
Maryland (86)
Massachusetts (558)
Michigan (87)
Minnesota (44)
Mississippi (1)
Missouri (29)
Montana (4)
Nebraska (5)
Nevada (10)
New Hampshire (9)
New Jersey (174)
New Mexico (11)
New York (230)
North Carolina (116)
North Dakota (3)
Northern California (382)
Ohio (61)
Oklahoma (3)
Oregon (8)
Pennsylvania (160)
Rhode Island (3)
South America (190)
South Carolina (8)
Southern California (275)
Tennessee (40)
Texas (132)
United States (3000)
Utah (53)
Virginia (19)
Washington D.C. (4)
Washington State (77)
West Virginia (2)
Wisconsin (21)
56,317 Results for "bioage labs".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference
November 26, 2025
·
1 min read
Press Releases
BioAge Labs to Present at Jefferies 2025 Global Healthcare Conference in London
November 10, 2025
·
1 min read
Press Releases
BioAge Announces Proposed Public Offering
January 21, 2026
·
5 min read
Press Releases
BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 6, 2025
·
10 min read
Press Releases
BioAge Labs to Present at Upcoming September 2025 Investor Conferences
August 21, 2025
·
1 min read
Press Releases
BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 7, 2025
·
10 min read
Weight loss
BioAge Drops Lead Obesity Asset Months After IPO
It’s been a rocky few months for BioAge Labs, which shuttered a Phase II trial of its lead candidate azelaprag Tuesday after the molecule caused liver-based side effects.
January 28, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
BioAge Announces Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
December 5, 2025
·
8 min read
Press Releases
BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
August 18, 2025
·
7 min read
Press Releases
BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates
May 7, 2025
·
9 min read
1 of 5,632
Next
